Published in:
01-12-2004 | Original
Withholding and withdrawing life-support therapy in an Emergency Department: prospective survey
Authors:
Philippe Le Conte, Denis Baron, David Trewick, Marie Dominique Touzé, Céline Longo, Irshaad Vial, Danielle Yatim, Gille Potel
Published in:
Intensive Care Medicine
|
Issue 12/2004
Login to get access
Abstract
Objectives
Few studies have focused on decisions to withdraw or withhold life-support therapies in the emergency department. Our objectives were to identify clinical situations where life-support was withheld or withdrawn, the criteria used by physicians to justify their decisions, the modalities necessary to implement these decisions, patient disposition, and outcome.
Design and setting
Prospective unicenter survey in an Emergency Department of a tertiary care teaching hospital.
Patients
All non-trauma patients (n=119) for whom a decision to withhold or withdraw life-sustaining treatments was taken between January and September 1998.
Main outcome measures
Choice of criteria justifying the decision to withhold or withdraw life-sustaining treatments, time interval from ED admission to the decision; type of decision implemented, outcome.
Results
Fourteen thousand eight hundred and seventy-five non-trauma patients were admitted during the study period, 119 were included, mean age 75±13 years. Resuscitation procedures were instituted for 96 (80%) patients before a subsequent decision was taken. Physicians chose on average 6±2 items to justify their decision; the principal acute medical disorder and futility of care were the two criteria most often used. Median time interval to reach the decision was 187 min. Withdrawal involved 37% of patients and withholding 63% of patients. The family was involved in the decision-making process in 72% of patients. The median time interval from the decision to death was 16 h (5 min to 140 days).
Conclusion
Withdrawing and withholding life-support therapy involved elderly patients with underlying chronic cardiopulmonary disease or metastatic cancer or patients with acute non-treatable illness.